Our Pricing

Stay On Any Wegovy Dose - Complete Range Available

Published on: June 03, 2026

Wondering if you can stay on low dose Wegovy UK rather than escalating to higher strengths? At Cured Pharmacy, we stock the complete range of Wegovy doses from 0.25mg to 2.4mg, allowing you and your UK prescriber to find the optimal maintenance dose for your individual needs. Many patients achieve their weight management goals on lower doses, and our clinical team supports personalised dosing strategies backed by your response and tolerability.

Understanding Wegovy Dose Escalation and Maintenance

Wegovy (semaglutide) follows a structured dose escalation schedule designed to minimise gastrointestinal side effects whilst building therapeutic effect [1]. The standard titration begins at 0.25mg weekly for four weeks, progressing through 0.5mg, 1mg, and 1.7mg, with 2.4mg as the target maintenance dose reached after 16-20 weeks.

However, clinical practice increasingly recognises that the 2.4mg target isn't universally necessary. In the STEP clinical trials, participants across all dose levels demonstrated significant weight reduction, with some achieving clinically meaningful results at sub-maximal doses [1]. Individual factors including baseline weight, metabolic response, side effect tolerance, and personal goals all influence optimal dosing.

At Cured Pharmacy, our UK prescribers assess your individual response at each dose level. If you're experiencing satisfactory weight loss and good tolerability on 0.5mg or 1mg, staying at that maintenance dose may be clinically appropriate rather than automatically escalating. This patient-centred approach prioritises your experience whilst maintaining safety and efficacy standards.

Can You Stay on Wegovy 0.25mg or 0.5mg Long-Term?

The 0.25mg and 0.5mg doses were primarily designed as titration steps to improve gastrointestinal tolerance during initiation [1]. However, some patients find these lower doses sufficient for appetite control and steady weight management, particularly those with lower starting BMI or significant lifestyle modifications in place.

Clinical evidence suggests that whilst higher doses produce greater average weight loss, individual response varies considerably [2]. A patient achieving 5-10% body weight reduction on 0.5mg with minimal side effects may not require escalation to 2.4mg, especially if that lower percentage meets their clinical goals and health improvement markers.

UK prescribers can authorise long-term maintenance on lower Wegovy doses when clinically justified. Factors supporting this decision include sustained weight loss or maintenance at current dose, absence of weight regain, good metabolic marker improvement, and intolerable side effects at higher doses. Your prescriber will review your progress regularly to ensure the chosen dose remains appropriate and effective for your ongoing weight management.

Clinical Scenarios for Lower Dose Maintenance

Several patient profiles benefit from staying on lower Wegovy doses. Older adults or those with multiple medications may experience better tolerability at 0.5mg or 1mg whilst still achieving meaningful weight loss. Patients who've reached their target weight on a lower dose can often maintain that loss without further escalation. Those experiencing significant nausea, vomiting, or gastrointestinal disturbance at higher doses may find lower doses provide the optimal balance between efficacy and quality of life. Your UK prescriber will individualise your treatment plan based on your clinical response and personal circumstances.

All Wegovy Doses Available at Cured Pharmacy

Supply consistency has been a significant challenge across the UK weight loss medication market. At Cured Pharmacy, we maintain stock across the full Wegovy dose range, ensuring continuity for patients at any stage of treatment. Our inventory includes 0.25mg, 0.5mg, 1mg, 1.7mg, and 2.4mg pens, allowing your prescriber complete flexibility in dosing decisions.

This comprehensive availability means you won't face forced treatment interruptions or unwanted dose changes due to supply gaps. Whether you're initiating treatment, escalating gradually, or maintaining on your optimal dose, we can dispense your prescribed strength. All Wegovy pens supplied are genuine UK-licensed products sourced through regulated pharmaceutical channels, meeting MHRA standards for quality and safety.

Pricing remains transparent and competitive, with treatment available with prescriber approval. Your final cost depends on the prescribed dose and treatment duration, which your UK clinician determines during your free online consultation. We never require payment before you know exactly what's been prescribed, ensuring complete transparency throughout your treatment journey.

How to Access Your Preferred Wegovy Dose

Start by completing our free online clinical assessment, which takes under three minutes. Provide accurate information about your current dose, how long you've been taking it, your weight loss progress, any side effects experienced, and your treatment goals. A UK-registered prescriber reviews your assessment, considering whether continuing your current dose, escalating, or adjusting is most appropriate for your circumstances. Once approved, we dispense your prescribed Wegovy dose with discreet next-day delivery across the UK. Regular follow-up consultations ensure your maintenance dose remains optimal as your weight management journey progresses.

Wegovy vs Mounjaro: Comparing Dose Flexibility

Both Wegovy and Mounjaro offer structured dose escalation schedules, but their mechanisms and dose ranges differ significantly. Mounjaro (tirzepatide) acts on both GIP and GLP-1 receptors, potentially producing greater weight loss at equivalent stages, with maintenance doses ranging from 5mg to 15mg weekly [3].

Clinical trials show Mounjaro participants achieved average weight reductions exceeding those seen with semaglutide-based treatments, with the SURPASS-3 trial demonstrating up to 22.5% body weight reduction at the highest dose over 72 weeks [3]. However, individual response remains variable, and some patients respond better to Wegovy's single-pathway mechanism.

At Cured Pharmacy, we stock both medications across all licensed doses. Your prescriber can help determine which treatment and dose level suits your medical profile, previous treatment response, and weight management goals. Switching between treatments or adjusting doses requires clinical assessment to ensure safety and continuity of care.

Managing Side Effects at Different Wegovy Doses

Gastrointestinal side effects including nausea, vomiting, diarrhoea, and constipation are the most commonly reported adverse events with Wegovy, typically dose-dependent and most prominent during escalation phases [1][2]. Staying on a lower dose where side effects are minimal whilst maintaining therapeutic benefit is a valid clinical strategy.

Most patients find side effects diminish after 4-8 weeks at each dose level as the body adapts to the medication. However, if symptoms persist or worsen, remaining at your current dose or even reducing temporarily may be appropriate. Your UK prescriber can adjust your treatment plan based on your tolerability whilst ensuring you continue receiving clinical benefit.

Practical management strategies include eating smaller, more frequent meals, avoiding high-fat foods that can worsen nausea, staying well-hydrated, and taking your injection on the same day each week to maintain steady medication levels. If side effects significantly impact your quality of life at higher doses, discuss maintenance on a lower dose with your prescriber rather than discontinuing treatment entirely.

When to Contact Your Prescriber About Dose Concerns

Seek clinical advice if you experience severe or persistent vomiting preventing adequate hydration, signs of pancreatitis including severe abdominal pain radiating to your back, symptoms of gallbladder problems such as upper abdominal pain with fever, rapid heart rate or dizziness suggesting dehydration, or any concerns about your treatment response or side effects. Your Cured Pharmacy prescriber can adjust your dose, provide management strategies, or determine if alternative treatment is more suitable. Never adjust your Wegovy dose independently without prescriber approval, as this can affect both safety and efficacy.

Long-Term Weight Management on Maintenance Wegovy Doses

Weight loss medications like Wegovy are most effective as part of comprehensive lifestyle modification including dietary changes and increased physical activity [2]. Your maintenance dose supports these efforts by reducing appetite, slowing gastric emptying, and improving satiety signals, making sustainable behaviour changes more achievable.

Clinical evidence from the STEP trials demonstrates that weight loss achieved with semaglutide can be maintained long-term when treatment continues, though some weight regain typically occurs if medication is discontinued [2]. This highlights that Wegovy functions as a chronic disease treatment rather than a short-term intervention, with ongoing use required for sustained benefit.

Regular monitoring by your UK prescriber ensures your maintenance dose remains appropriate as your weight stabilises. Some patients find they can maintain their weight loss on a lower dose once they've reached their goal, whilst others require their current dose to prevent regain. Your prescriber will work with you to find the minimum effective dose that maintains your weight management success whilst minimising side effects and treatment costs. At Cured Pharmacy, we support your long-term treatment journey with consistent supply, transparent pricing, and ongoing clinical guidance from our UK-registered team.

Scientific References

1. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Rubino, D., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 [accessed 13 August 2026]
3. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
4. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
5. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
6. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication or adjusting your current dose.